Brief: MedinCell Signs Licence Deal With Medicines Patent Pool For Malaria
13/09/2022 17:10
Sept 13 (Reuters) - MEDINCELL SA MEDCL.PA :
* MEDINCELL SIGNS A LICENCE AGREEMENT WITH THE MEDICINES
PATENT
POOL TO FIGHT MALARIA TRANSMISSION, AS PART OF ITS GLOBAL HEALTH
MISSION
* LICENCE AGREEMENT RELATES TO A 3-MONTH ACTIVE INJECTABLE
FORMULATION OF IVERMECTIN USING MEDINCELL'S BEPO® TECHNOLOGY TO
FIGHT MALARIA TRANSMISSION
* LICENCE AGREEMENT AIMS TO ENSURE THAT PRODUCT BE WIDELY
DISTRIBUTED IN LOW- AND MIDDLE-INCOME COUNTRIES IF PROVEN
EFFECTIVE AND SAFE
Source text for Eikon: ID:nBw444PLXa
Further company coverage: MEDCL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))